Skip to main contentSkip to navigation
Sirius Investors
NeonMind Biosciences Inc.

NeonMind Biosciences Inc.

NMDBF
OTC•Healthcare

Market Capitalization & Enterprise Value

Research-grade valuation history for NMDBF. Track market capitalization versus enterprise value to see the impact of net debt and share changes. Use the interactive chart to explore different horizons; the table updates accordingly to support auditability and export.

Quick links:Overview•Financial Metrics•Technicals•Returns•Financials•Performance

Market Cap & Enterprise Value

Comparison of market capitalization and enterprise value over time

Market Cap

Market Capitalization = Stock Price × Number of Shares Outstanding. Represents the total value of a company's equity.
11.01K
N/A over period

Enterprise Value

Enterprise Value = Market Cap + Total Debt - Cash and Cash Equivalents. Represents the total value of a company including its debt.
822.13K
N/A over period

Market Cap History

Investor Valuation Insights

As of Feb 28, 2023

EV/EBITDA

Potentially Cheap

3.10x

Lower EV/EBITDA can indicate attractive valuation relative to operating earnings.

EV vs Market Cap Spread

811.12K

EV is +7365.8% vs equity value

Capital Structure Signal

Net Debt Profile

Trend unavailable for selected history

Additional Multiples

EV/Sales: 0.00x

Net Debt/EBITDA: 3.05x

Share count trend unavailable

Interpretation guide: EV/EBITDA compares total firm value (debt + equity - cash) to operating earnings. Lower is usually cheaper, but always benchmark against peers, growth rate, margins, and cyclicality.

Market Cap & Enterprise Value Data

Free users can view the latest 3 records. Upgrade to see full history.

Upgrade
DateMarket CapEnterprise ValueStock PriceShares
Nov 30, 202211.01K822.13K$0.2937.72K
Nov 30, 20218.82M8.50M$8.97983.30K
Nov 30, 202033.99M34.68M$36.28936.92K
Nov 30, 2019
————

Enterprise Value Analysis

Price Change (Nov 2021 to Nov 2022)

The stock price has decreased from Nov 2021 to Nov 2022.
-96.75%

Recent Volatility

The stock price has been relatively volatile over the last 3 periods, indicating a higher risk profile.
0.11

Risk-Adjusted Return

The stock's returns do not compensate for its risk level, suggesting a poor risk-reward profile.
-8.01

Market Cap Change (Nov 2021 to Nov 2022)

The company's market capitalization has decreased from Nov 2021 to Nov 2022.
-99.88%

Enterprise Value Change (Nov 2021 to Nov 2022)

The company's enterprise value has decreased from Nov 2021 to Nov 2022, suggesting a decline in the company's total economic value.
-90.32%

Market Cap vs. Enterprise Value

A higher enterprise value growth rate compared to market cap growth could indicate that the company is investing heavily in growth initiatives or taking on more debt.
EV Growth > Market Cap Growth

Market Cap CAGR

The Compound Annual Growth Rate (CAGR) of market capitalization represents the mean annual growth rate over the entire available history (3 periods), accounting for compounding effects.
-98.20%

Enterprise Value CAGR

The Compound Annual Growth Rate (CAGR) of enterprise value represents the mean annual growth rate over the entire available history (3 periods), accounting for compounding effects.
-84.60%